Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,488 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study.
Nagasaka K, Kawana K, Tomio K, Tsuruga T, Mori-Uchino M, Miura S, Tanikawa M, Miyamoto Y, Ikeda Y, Sone K, Adachi K, Matsumoto Y, Arimoto T, Oda K, Osuga Y, Fujii T. Nagasaka K, et al. Among authors: ikeda y. J Obstet Gynaecol Res. 2015 May;41(5):755-62. doi: 10.1111/jog.12616. Epub 2014 Nov 25. J Obstet Gynaecol Res. 2015. PMID: 25421004
Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway.
Murayama-Hosokawa S, Oda K, Nakagawa S, Ishikawa S, Yamamoto S, Shoji K, Ikeda Y, Uehara Y, Fukayama M, McCormick F, Yano T, Taketani Y, Aburatani H. Murayama-Hosokawa S, et al. Among authors: ikeda y. Oncogene. 2010 Apr 1;29(13):1897-908. doi: 10.1038/onc.2009.474. Epub 2010 Jan 11. Oncogene. 2010. PMID: 20062086
Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer.
Ikeda Y, Oda K, Nakagawa S, Murayama-Hosokawa S, Yamamoto S, Ishikawa S, Wang L, Takazawa Y, Maeda D, Wada-Hiraike O, Kawana K, Fukayama M, Aburatani H, Yano T, Kozuma S, Taketani Y. Ikeda Y, et al. Int J Gynecol Cancer. 2012 Jun;22(5):725-31. doi: 10.1097/IGC.0b013e31824c6ea6. Int J Gynecol Cancer. 2012. PMID: 22635024 Free article.
Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.
Shoji K, Oda K, Kashiyama T, Ikeda Y, Nakagawa S, Sone K, Miyamoto Y, Hiraike H, Tanikawa M, Miyasaka A, Koso T, Matsumoto Y, Wada-Hiraike O, Kawana K, Kuramoto H, McCormick F, Aburatani H, Yano T, Kozuma S, Taketani Y. Shoji K, et al. Among authors: ikeda y. PLoS One. 2012;7(5):e37431. doi: 10.1371/journal.pone.0037431. Epub 2012 May 25. PLoS One. 2012. PMID: 22662154 Free PMC article.
Role of multifunctional transcription factor TFII-I and putative tumour suppressor DBC1 in cell cycle and DNA double strand damage repair.
Tanikawa M, Wada-Hiraike O, Yoshizawa-Sugata N, Shirane A, Hirano M, Hiraike H, Miyamoto Y, Sone K, Ikeda Y, Kashiyama T, Oda K, Kawana K, Katakura Y, Yano T, Masai H, Roy AL, Osuga Y, Fujii T. Tanikawa M, et al. Among authors: ikeda y. Br J Cancer. 2013 Dec 10;109(12):3042-8. doi: 10.1038/bjc.2013.532. Epub 2013 Nov 14. Br J Cancer. 2013. PMID: 24231951 Free PMC article.
5,488 results